
-
2009
Company Description
cCAM Biotherapeutics is a pre-clinical stage company that develops immunotherapies for cancer.
cCAM Biotherapeutics is a pre-clinical stage company developing immunotherapies for cancer. cCAM's lead agent, CM-10, is an immunomodulatory antibody that harnesses the patient's immune system to attack tumors. CM-10 binds CEACAM1, a protein used by cancer cells to suppress the immune system. CM-10 abrogates this effect, leading to a cancer specific immune response in patients.
-
Manufacturer:
Science and Engineering -
Formed:
2009 -
Founders:
Gal Markel -
Company Website:
-
Company E-mail:
-
Company Address:
Tel-Hai Industrial ParkQiryat ShmonaIsrael -
CEO:
- Gal Markel
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits